AMEX:XBI   SPDR Series Trust SPDR S&P Biotech ETF
After a whole year of just performing like trash, XBI is now at covid levels. It literally gave up all the gains it made in 2020 in 2021.
It is currently at a monthly SR level and volume area, while also being at the long term trendline. I'm expecting this to turn around and at least hit ~$115 again, but who knows, it's the XBI after all.

면책사항

이 정보와 게시물은 TradingView에서 제공하거나 보증하는 금융, 투자, 거래 또는 기타 유형의 조언이나 권고 사항을 의미하거나 구성하지 않습니다. 자세한 내용은 이용 약관을 참고하세요.